MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.02.2026
Adaptive Biotechnologies Corporation P/S 2011-2026 | ADPT
P/S Jährlich Adaptive Biotechnologies Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.96 | 6.58 | 3.5 | 6.62 | 13.1 | 75.4 | 25.1 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 75.4 | 3.5 | 19.9 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.15 | -2.68 % | $ 2.54 B |  USA |
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
105 | $ 0.82 | -3.48 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
13.6 | $ 163.7 | -1.61 % | $ 8.14 B | USA |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
AbCellera Biologics
ABCL
|
12.8 | $ 3.72 | -2.75 % | $ 1.11 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
6.35 | $ 8.52 | -2.46 % | $ 1.39 B | Britain |
 |
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
Certara
CERT
|
2.57 | $ 7.16 | 1.49 % | $ 1.15 B | USA |
 |
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
6.17 | $ 25.91 | -3.56 % | $ 694 M | USA |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | Canada |
 |
Codexis
CDXS
|
4.91 | $ 0.99 | -3.28 % | $ 72.7 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
5.16 | $ 24.0 | 0.5 % | $ 2.93 B | USA |
 |
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
0.00137 | $ 3.19 | -4.64 % | $ 1.14 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M |  Israel |
 |
Agios Pharmaceuticals
AGIO
|
30.2 | $ 28.78 | -1.44 % | $ 1.67 B | USA |
 |
Champions Oncology
CSBR
|
1.86 | $ 6.0 | -1.15 % | $ 82 M | USA |
 |
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
1.28 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
5.39 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
6.69 | $ 3.67 | -3.42 % | $ 116 M |  France |
 |
Alector
ALEC
|
11.7 | $ 2.11 | -4.75 % | $ 217 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
11.4 | $ 15.68 | -2.4 % | $ 779 M | Britain |
 |
Altimmune
ALT
|
23.1 K | $ 4.17 | 0.24 % | $ 296 M | USA |
 |
Teligent, Inc.
TLGT
|
0.111 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
36.6 | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | USA |
 |
Amarin Corporation plc
AMRN
|
27.2 | $ 14.27 | 2.44 % | $ 5.92 B |  Irlanda |